TY - CHAP M1 - Book, Section TI - Osteoporosis Medication Therapy Management Data Set A1 - Rose, Renee L. A2 - Angaran, David M. A2 - Whalen, Karen Y1 - 2015 N1 - T2 - Medication Therapy Management: A Comprehensive Approach AB - MTM providers should screen for medications that are associated with an increased risk of osteoporosis and recommend bone mineral density testing to the primary provider if appropriate.Adequate intake of calcium as well as vitamin D is essential for prevention and treatment of osteoporosis. Evaluating dietary calcium intake can help the provider determine the additional amount of calcium supplementation a patient requires.Calcium carbonate is the salt of choice for calcium supplementation because it has the highest amount of elemental calcium and is the least expensive; however, calcium citrate should be considered for elderly patients with low acid production and those on acid-reducing medications.MTM providers should assess whether patients are appropriately administering bisphosphonate therapy (ie, taking the medication on an empty stomach 30 minutes before any food, medication, or vitamins and remaining upright for 30 minutes) and counsel them on the importance of appropriate administration to reduce adverse effects and maximize efficacy of therapy.Patient adherence to bisphosphonate therapy tends to be poor, decreasing its efficacy. MTM providers should screen for nonadherence and recommend changes in pharmacotherapy or other methods to improve adherence. SN - PB - McGraw-Hill Education CY - New York, NY Y2 - 2024/03/29 UR - accesspharmacy.mhmedical.com/content.aspx?aid=1102489533 ER -